Warning: The NCBI web site requires JavaScript to function. more...
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.
Gallo SA, Reeves JD, Garg H, Foley B, Doms RW, Blumenthal R.
Retrovirology. 2006 Dec 4;3:90.
Related citations
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Gallo SA, Puri A, Blumenthal R.
Biochemistry. 2001 Oct 16;40(41):12231-6.
Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.
Miyauchi K, Kozlov MM, Melikyan GB.
PLoS Pathog. 2009 Sep;5(9):e1000585. Epub 2009 Sep 18.
Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ, Baik SS, Doms RW.
J Virol. 1999 Dec;73(12):10346-58.
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
Finnegan CM, Berg W, Lewis GK, DeVico AL.
J Virol. 2001 Nov;75(22):11096-105.
The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S, Rawat SS, Viard M, Wang JM, Puri A, Blumenthal R.
Virol J. 2006 Dec 22;3:104.
Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
J Virol. 2002 Dec;76(23):12123-34.
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
Reeves JD, Gallo SA, Ahmad N, Miamidian JL, Harvey PE, Sharron M, Pohlmann S, Sfakianos JN, Derdeyn CA, Blumenthal R, Hunter E, Doms RW.
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54. Epub 2002 Nov 20.
The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
J Mol Biol. 2004 Jun 25;340(1):9-14.
Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
Lin G, Baribaud F, Romano J, Doms RW, Hoxie JA.
J Virol. 2003 Jan;77(2):931-42.
Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
Xiao X, Norwood D, Feng YR, Moriuchi M, Jones-Trower A, Stantchev TS, Moriuchi H, Broder CC, Dimitrov DS.
Exp Mol Pathol. 2000 Jun;68(3):139-46.
Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanism.
Ray PE, Soler-García AA, Xu L, Soderland C, Blumenthal R, Puri A.
Pediatr Nephrol. 2005 Oct;20(10):1401-9. Epub 2005 Jul 27.
Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X, Kinter A, Broder CC, Dimitrov DS.
Exp Mol Pathol. 2000 Jun;68(3):133-8.
Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.
Dimitrov AS, Xiao X, Dimitrov DS, Blumenthal R.
J Biol Chem. 2001 Aug 10;276(32):30335-41. Epub 2001 Jun 7.
Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.
Markovic I, Stantchev TS, Fields KH, Tiffany LJ, Tomiç M, Weiss CD, Broder CC, Strebel K, Clouse KA.
Blood. 2004 Mar 1;103(5):1586-94. Epub 2003 Oct 30.
CD4 activation of HIV fusion.
Sattentau QJ.
Int J Cell Cloning. 1992 Nov;10(6):323-32. Review.
The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
Melikyan GB, Platt EJ, Kabat D.
Retrovirology. 2007 Aug 8;4:55.
Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
Barbouche R, Miquelis R, Jones IM, Fenouillet E.
J Biol Chem. 2003 Jan 31;278(5):3131-6. Epub 2002 Sep 5.
Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
Chabot DJ, Zhang PF, Quinnan GV, Broder CC.
J Virol. 1999 Aug;73(8):6598-609.
Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, Golding H.
AIDS. 1992 Mar;6(3):249-56.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on